Showing results (2331-2340 of 6,794) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|August 19, 2007
Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled studyAllan Gibofsky, Jude Rodrigues, Justus Fiechtner, et al.Clinical Therapeutics|August 19, 2007
Retrospective analysis of electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteersZaiqi Wang, Dennis M Grasela, Gopal KrishnaClinical Therapeutics|August 19, 2007
A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumoniaMeghan N Jeffres, Warren Isakow, Joshua A Doherty, et al.Clinical Therapeutics|August 19, 2007
Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy studyHumberto Quintana, Edward A Cherlin, David A Duesenberg, et al.Clinical Therapeutics|August 19, 2007
Inhaled dry powder insulin for the treatment of diabetes mellitusStephen M Setter, Terri L Levien, Jason L Iltz, et al.Clinical Therapeutics|August 19, 2007
Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III studyAndrew Lewin, Robert Lipetz, Jacqueline Wu, et al.Clinical Therapeutics|August 19, 2007
Prevention of pain due to injection of propofol with IV administration of lidocaine 40 mg + metoclopramide 2.5, 5, or 10 mg or saline: a randomized, double-blind study in Japanese adult surgical patientsYoshitaka Fujii, Masahiro NakayamaClinical Therapeutics|August 19, 2007
Empiric therapy for secondary peritonitis: a pharmacodynamic analysis of cefepime, ceftazidime, ceftriaxone, imipenem, levofloxacin, piperacillin/tazobactam, and tigecycline using Monte Carlo simulationKathryn J Eagye, Joseph L Kuti, Michael Dowzicky, et al.Clinical Therapeutics|March 27, 2012
Dabigatran etexilate: an oral direct thrombin inhibitor for the management of thromboembolic disordersJudy W M Cheng, Huyen VuClinical Therapeutics|March 27, 2012
Ceftaroline fosamil: a cephalosporin with activity against methicillin-resistant Staphylococcus aureusHenry Poon, Mei H Chang, Horatio B FungPageof 680